−0.25SEK
−6.90 MSEK
139.46 KSEK
About ODI PHARMA AB
Sector
CEO
Derek Simmross
Headquarters
Stockholm
Website
Founded
2018
ISIN
SE0013409760
FIGI
BBG00R3WJJ40
ODI Pharma AB is a pharmaceutical company, which engages in the provision of finished pharmaceutical cannabis and cosmetics products with a focus on distribution to the medical cannabis industry. The company was founded by Derek Simmross and Volker Wiederrich in 2018 and is headquartered Stockholm, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ODI is 5.70 SEK — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NGM exchange ODI PHARMA AB stocks are traded under the ticker ODI.
ODI stock is 0% volatile and has beta coefficient of 1.47. Check out the list of the most volatile stocks — is ODI PHARMA AB there?
Yes, you can track ODI PHARMA AB financials in yearly and quarterly reports right on TradingView.
ODI stock has risen by 4.59% compared to the previous week, the month change is a 9.62% rise, over the last year ODI PHARMA AB has showed a 20.25% increase.
ODI net income for the last quarter is 946.53 K SEK, while the quarter before that showed −1.44 M SEK of net income which accounts for 165.61% change. Track more ODI PHARMA AB financial stats to get the full picture.
Today ODI PHARMA AB has the market capitalization of 86.75 M, it has increased by 4.76% over the last week.
No, ODI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ODI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ODI PHARMA AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ODI PHARMA AB technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ODI PHARMA AB stock shows the buy signal. See more of ODI PHARMA AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ODI PHARMA AB EBITDA is −6.58 M SEK, and current EBITDA margin is −4.88 K%. See more stats in ODI PHARMA AB financial statements.